Literature DB >> 7365353

Response of atrial fibrillation to therapy: role of etiology and left atrial diameter.

G A Ewy, L Ulfers, W D Hager, A R Rosenfeld, W R Roeske, S Goldman.   

Abstract

Left atrial diameter was measured by echocardiography in 107 patients in atrial fibrillation. The etiology of atrial fibrillation was rheumatic heart disease with predominant mitral valve involvement (RHD) in 51 patients and idiopathic atrial fibrillation (IAF) in 56. The left atrial diameter was correlated to the patient's response to therapy. The mean left atrial diameter was 3.4 cm in patients with paroxysmal atrial fibrillation, 3.8 cm in those requiring direct current (DC) cardioversion, and 4.4 cm in patients with persistent atrial fibrillation. However, in each of these therapeutic response groups, the left atrial diameter was signficantly smaller in patients with idiopathic atrial fibrillation. In the group with paroxysmal atrial fibrillation, the mean left atrial diameter was 4.3 +/- .7 cm in patients with RHD, compared to 3.1 +/- .6 cm in those with IAF (p less than .001). In the group requiring DC cardioversion, the left atrial diameter was 4.7 +/- .8 cm in patients with RHD compared to 3.6 +/- .5 cm in those with IAF (p less than .01). In patients with persistent atrial fibrillation, the left atrial diameter was 5.2 +/- .9 cm in patients with RHD and 4.0 +/- 1.0 cm in IAF (p less than .001). Left atrial diameter as well as the etiology of the heart disease are important in determining the response of atrial fibrillation to therapy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7365353     DOI: 10.1016/s0022-0736(80)80042-2

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  7 in total

Review 1.  Chronic and paroxysmal atrial fibrillation: course, prognosis, and stroke risk.

Authors:  T E Cuddy
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

2.  Echocardiographic Predictors of Symptomatic Atrial Fibrillation In Patients with Rheumatic Mitral Stenosis and Normal Sinus Rhythm.

Authors:  Fahriye Vatansever Agca; Ozan Kinay; Mustafa Karaca; Muge Ildizli Demirbas; Serdar Biceroglu; Baris Kilicarslan; Cem Nazli; A Oktay Ergene
Journal:  J Atr Fibrillation       Date:  2008-09-16

3.  Effects of P-wave dispersion on atrial fibrillation in patients with acute anterior wall myocardial infarction.

Authors:  Merih Baykan; Sükrü Celik; Cevdet Erdöl; Ismet Durmuş; Cihan Orem; Mehmet Küçükosmanoğlu; Remzi Yilmaz
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-04       Impact factor: 1.468

4.  A non-invasive method to predict electrical cardioversion outcome of persistent atrial fibrillation.

Authors:  Raúl Alcaraz; José Joaquín Rieta
Journal:  Med Biol Eng Comput       Date:  2008-04-24       Impact factor: 2.602

5.  Determinants of recurrent atrial flutter after cardioversion.

Authors:  R G Pozen; J Pastoriza; J J Rozanski; K M Kessler; R J Myerburg
Journal:  Br Heart J       Date:  1983-07

6.  Functional capacity before and after cardioversion of atrial fibrillation: a controlled study.

Authors:  A T Gosselink; H J Crijns; M P van den Berg; S A van den Broek; H Hillege; M L Landsman; K I Lie
Journal:  Br Heart J       Date:  1994-08

Review 7.  The treatment of atrial fibrillation. An evaluation of drug therapy, electrical modalities and therapeutic considerations.

Authors:  S Nattel; T Hadjis; M Talajic
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.